IT1401083B1 - Composizione per il trattamento e la prevenzione dell'herpes simplex labiale. - Google Patents

Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.

Info

Publication number
IT1401083B1
IT1401083B1 ITFI2010A000159A ITFI20100159A IT1401083B1 IT 1401083 B1 IT1401083 B1 IT 1401083B1 IT FI2010A000159 A ITFI2010A000159 A IT FI2010A000159A IT FI20100159 A ITFI20100159 A IT FI20100159A IT 1401083 B1 IT1401083 B1 IT 1401083B1
Authority
IT
Italy
Prior art keywords
labiale
prevention
treatment
composition
herpes simplex
Prior art date
Application number
ITFI2010A000159A
Other languages
English (en)
Inventor
Costantino Pasquali
Original Assignee
Pasquali S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasquali S R L filed Critical Pasquali S R L
Priority to ITFI2010A000159A priority Critical patent/IT1401083B1/it
Priority to PCT/IT2011/000179 priority patent/WO2012014238A1/en
Priority to EP11738830.6A priority patent/EP2598132B1/en
Publication of ITFI20100159A1 publication Critical patent/ITFI20100159A1/it
Application granted granted Critical
Publication of IT1401083B1 publication Critical patent/IT1401083B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
ITFI2010A000159A 2010-07-27 2010-07-27 Composizione per il trattamento e la prevenzione dell'herpes simplex labiale. IT1401083B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITFI2010A000159A IT1401083B1 (it) 2010-07-27 2010-07-27 Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.
PCT/IT2011/000179 WO2012014238A1 (en) 2010-07-27 2011-05-27 Composition for the treatment and prevention of herpes simplex labialis
EP11738830.6A EP2598132B1 (en) 2010-07-27 2011-05-27 Composition for the treatment and prevention of herpes simplex labialis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI2010A000159A IT1401083B1 (it) 2010-07-27 2010-07-27 Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.

Publications (2)

Publication Number Publication Date
ITFI20100159A1 ITFI20100159A1 (it) 2012-01-28
IT1401083B1 true IT1401083B1 (it) 2013-07-12

Family

ID=43628688

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI2010A000159A IT1401083B1 (it) 2010-07-27 2010-07-27 Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.

Country Status (3)

Country Link
EP (1) EP2598132B1 (it)
IT (1) IT1401083B1 (it)
WO (1) WO2012014238A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20152286A1 (it) * 2015-07-17 2017-01-17 Harven S A S Composizione anti herpes
FR3083450B1 (fr) 2018-07-04 2021-05-07 Laboratoire Mawena Composition huileuse contenant un extrait de mimosa tenuiflora et utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140809A (en) * 1983-06-01 1984-12-05 Biorex Laboratories Ltd New derivatives of glycyrrhetinic acid
JPH06345748A (ja) * 1993-06-15 1994-12-20 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス活性を有する新規グリチルレチン酸誘導体
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
WO2008010241A1 (en) * 2006-07-18 2008-01-24 D.M.G. Italia Srl A liposomal complex of sodium carboxymethyl beta-glucan
EP2337544A2 (en) * 2007-04-30 2011-06-29 Living Proof, Inc. Use of matrix metalloproteinase inhibitors in skin care
WO2010045969A1 (en) * 2008-10-21 2010-04-29 Naturveda New synergic association for the treatment of deep skin or mucosa injuries

Also Published As

Publication number Publication date
ITFI20100159A1 (it) 2012-01-28
EP2598132A1 (en) 2013-06-05
EP2598132B1 (en) 2014-12-17
WO2012014238A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
PL2768937T3 (pl) Preparaty, ich zastosowanie jako środków do mycia naczyń lub do wytwarzania środków do mycia naczyń i ich wytwarzanie
EP2552433A4 (en) COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES
ES2525801T8 (es) Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes
EP2542255A4 (en) METHOD AND COMPOSITIONS FOR TREATING THE DEGOS SYNDROME
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
EP2686688A4 (en) SYSTEMS AND COMPOSITIONS FOR DIAGNOSIS OF BARRETT OSOPHAGES AND METHOD OF USE THEREOF
GB0921075D0 (en) Novel combination of the therapeutic agents
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
HRP20150117T1 (en) Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
WO2011113060A3 (en) Antiviral compounds and methods of use thereof
EP2236150A4 (en) METHOD FOR INCREASING THE THERAPEUTIC EFFECTIVENESS OF CURCUMINOIDS AND THE LIKE
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
GB2497453B8 (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
BRPI1013245A2 (pt) "composto para o tratamento de distúrbios metabólicos"
SMT201500124B (it) Composizioni di bifosfonati e metodi per il trattamento dell'insufficienza cardiaco
WO2012082862A3 (en) Androgen receptor inhibitors and methods of use thereof
HK1197235A1 (zh) 二氫吡唑、其藥物組合物及其治療生育障礙的用途
IL224029A (en) Triazine and pyrimidine compounds, preparations containing them and their use in the treatment of insects
BR112013015048A2 (pt) composição para o tratamento de distúrbios metabólicos
IT1401083B1 (it) Composizione per il trattamento e la prevenzione dell'herpes simplex labiale.